◄ back to all posts
Financial data and stock pages provided for FREE by
Fintel.io
RIOT: Riot Blockchain Inc Stock
Written by | Jul, 6, 2018
Print FriendlySIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 31.91 |
| Enterprise Value ($M) | 30.66 |
| Book Value ($M) | -7.25 |
| Book Value / Share | -0.49 |
| Price / Book | -4.58 |
| NCAV ($M) | -21.32 |
| NCAV / Share | -1.44 |
| Price / NCAV | -1.56 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -10.40 |
| Return on Assets (ROA) | -1.15 |
| Return on Equity (ROE) | -1.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | 0.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.89 |
| Assets | 15.45 |
| Liabilities | 24.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 7.85 |
| Operating Income | -59.37 |
| Net Income | -60.21 |
| Earnings Per Share Basic And Diluted | -4.33 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -19.05 |
| Cash from Investing | -24.86 |
| Cash from Financing | -24.86 |
Source: Fintel.io |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Calc Iii Lp | 4.40 | ||
| 13G/A | Susquehanna Securities | 3.00 | ||
| 13G/A | Hudson Bay Capital Management LP | 2.25 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
Source: Fintel.io |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
Source: Fintel.io |
||||
| Similar Companies | |
|---|---|
| RGLS – Regulus Therapeutics Inc. | RGNX – REGENXBIO Inc. |
| RIGL – Rigel Pharmaceuticals, Inc. | RLYP – Relypsa, Inc. |
| RPGN – REPLIGEN CORP |
Financial data and stock pages provided for FREE by
Fintel.io
